menu search

Biogen shares fall after fda approval of alzheimer's drug leqembi

Stocks often react differently from the way you think they might. That happened on July 7 as shares of Biogen Inc. NASDAQ: BIIB swooned 2.88% in heavy...

July 10, 2023, 7:11 am

Biogen and alzheimer's disease: too early to celebrate

The FDA has granted full approval to Biogen and Eisai's anti-amyloid antibody drug leqembi, but there i...

July 9, 2023, 11:52 pm

Medicare will pay for alzheimer's drug leqembi. what patients and doctors should know

Patients with early Alzheimer's disease could still pay more than $5,000 in out-of-pocket costs for leqembi...

July 8, 2023, 7:00 am

Sales of alzheimer's drug leqembi may be slow initially but could pick up in 2024

Analysts believe the Medicare registry requirement and new guidance on leqembi's prescription label cou...

July 7, 2023, 1:59 pm

Biogen's alzheimer's drug rollout could be slow

Biogen has said it doesn't expect to clear a profit on Alzheimer's treatment leqembi, which was approve...

July 7, 2023, 1:17 pm

Eisai-biogen's alzheimer's treatment drug receives fda approval

Shares of Biogen and Eisai are lower amid news of label updates to the FDA officially approved the Alzheimer's treatment drug ...

July 7, 2023, 11:15 am

Will watershed moment for alzheimer's propel biogen stock higher?

Esai and Biogen's Alzheimer's Disease therapeutic, leqembi, received full FDA approval on July 6th. Ful...

July 7, 2023, 10:20 am

Biogen's stock slides premarket as analysts take mixed view of alzheimer's disease drug approval

Biogen Inc.'s stock BIIB, -0.31% rose about 2% before paring those gains premarket Friday, after the U.S. Food and Drug Administration on Thursday gra...

July 7, 2023, 7:29 am

Alzheimer's drug, the first to slow disease progression, gets fda green light

Eisai, a Japanese firm, and American drugs giant Biogen Inc (NASDAQ:BIIB) have received full Food & Drug Administration approval for ...

July 7, 2023, 2:58 am

Many health systems are already ready for 'leqembi' roll out, says eisai ceo ivan cheung

Ivan Cheung, Eisai U.S. CEO, joins 'Fast Money' to discuss the FDA approving Biogen's 'leqembi' Alzheim...

July 6, 2023, 7:03 pm

Fda approves leqembi, extending alzheimer's treatment to more patients

Medicare enrollees can get the anti-amyloid treatment as a result of the agency's full approval....

July 6, 2023, 6:57 pm

Fda grants full approval for alzheimer's drug, despite concerns

leqembi costs $26,000 per year before insurance....

July 6, 2023, 5:30 pm

Fda approves biogen and eisai alzheimer's treatment leqembi

The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB and Eisai Co. Ltd. ESALF Alzheimer's treatment ...

July 6, 2023, 4:55 pm

Fda approves alzheimer's drug leqembi, paving way for broader medicare coverage

leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries seriou...

July 6, 2023, 4:44 pm

Does this signal trouble for biogen's new alzheimer's drug?

Some European Alzheimer's experts are wary about the future of Biogen's drug leqembi in the region. Reg...

June 19, 2023, 5:30 am

Biogen shares rise on imminent approval of alzheimer's drug following fda panel vote

Biogen Inc (NASDAQ:BIIB) shares rose in pre-market trading on Monday after a Food and Drug Administration (FDA) panel voted in favor of Eisai and Biog...

June 12, 2023, 8:46 am

Biogen rises as fda panel backs alzheimer's drug, easing safety concerns

Shares of Biogen Inc rose 4% in premarket trade on Monday as an unanimous backing of the company's Alzheimer's drug ...

June 12, 2023, 6:26 am

Biogen inches closer to fda approval for its alzheimer's drug

Shares of Biogen Inc (NASDAQ: BIIB) gained nearly 10% in extended hours after the biotech firm edged closer to winning FDA approval for its Alzheimer'...

June 10, 2023, 2:33 pm

Fda advisory committee votes unanimously to confirm the clinical benefit of leqembi® (lecanemab-irmb) for the treatment of alzheimer’s disease

Peripheral and Central Nervous System Drugs Advisory Committee voted based on data from large global confirmatory Phase 3 Clarity AD clinical trial in...

June 9, 2023, 10:45 pm

Here's what the fda's endorsement of the alzheimer's drug leqembi means for biogen

Matt Herper, Stat News senior writer, joins 'Closing Bell: Overtime' to discuss the FDA advisers' unanimous vote to recommend Biogen Alzheimer's drug....

June 9, 2023, 5:33 pm


Search within

Pages Search Results: